Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gamida Cell Ltd
(NQ:
GMDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gamida Cell Ltd
< Previous
1
2
3
4
5
6
7
Next >
38 Stocks Moving In Thursday's Mid-Day Session
January 20, 2022
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering. Vertical Aerospace Ltd. (NYSE...
Via
Benzinga
Hot Penny Stocks: What’s Moving VVOS, GMDA and SBEV Higher Today?
January 19, 2022
Several penny stocks are on the move Wednesday and we're diving into the hot news behind that momentum with a quick dive into the space.
Via
InvestorPlace
35 Stocks Moving In Wednesday's Mid-Day Session
January 19, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion. Splash Beverage Group,...
Via
Benzinga
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
January 20, 2022
Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Mid-Morning Market Update: Markets Rise; Bank of America Posts Upbeat Profit
January 19, 2022
Following the market opening Wednesday, the Dow traded up 0.12% to 35,411.14 while the NASDAQ rose 0.90% to 14,638.13. The S&P also rose, gaining, 0.44% to 4,597.47. The U.S....
Via
Benzinga
52 Biggest Movers From Yesterday
January 20, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...
Via
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)...
Via
Benzinga
Gamida Cell Says Planning To Initiate Rolling BLA Submission For Omidubicel; Full BLA Submission On Track For 1H 2022
January 19, 2022
Planning to initiate rolling BLA submission for omidubicel following positive Type B meeting with FDA Full BLA submission on track for first half of 2022 BOSTON--(BUSINESS WIRE...
Via
Benzinga
Gamida Cell Provides Update on Omidubicel BLA Submission
January 19, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
January 07, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Harvest The Chaff?
December 31, 2021
This time of year, investors are dumping their worst performers for what is called tax-loss harvesting. Here are a hodgepodge of particularly-battered issues which you might consider as bounce plays...
Via
Talk Markets
45 Biggest Movers From Yesterday
December 30, 2021
Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter. United Time Technology Co., Ltd. (NASDAQ: UTME...
Via
Benzinga
26 Stocks Moving In Wednesday's Mid-Day Session
December 29, 2021
Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 38.4% to $1.55 after surging 43...
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
December 29, 2021
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) rose 95.5% to $2.19 in pre-market trading after surging 43% on Tuesday. Pop Culture Group Co., Ltd (NASDAQ: CPOP) rose 24.2% to $2.87 in...
Via
Benzinga
45 Biggest Movers From Yesterday
December 29, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze. ShiftPixy...
Via
Benzinga
25 Stocks Moving In Tuesday's Mid-Day Session
December 28, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze. Flotek Industries, Inc. (NYSE...
Via
Benzinga
Gamida Cell Ltd. (NASDAQ:GMDA) Shareholder Alert: Investigation over Possible Violations of Securities Laws
December 13, 2021
San Diego, CA -- (SBWIRE) -- 12/13/2021 -- Gamida Cell Ltd is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Exposures
Product Safety
Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual Meeting
December 13, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
December 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
November 16, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Ltd. (GMDA) Q3 2021 Earnings Call Transcript
November 16, 2021
GMDA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update
November 15, 2021
From
Gamida Cell Ltd.
Via
Business Wire
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...
Via
Benzinga
Gamida Cell Provides Update on Pre-BLA Meeting With FDA for Omidubicel
November 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents New Data on Nicotinamide-Enabled NK Cell Therapy at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
November 09, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Third Quarter 2021 Financial Results and Webcast
November 08, 2021
From
Gamida Cell Ltd.
Via
Business Wire
26 Stocks Moving in Monday's Pre-Market Session
November 08, 2021
Gainers Autolus Therapeutics plc (NASDAQ: AUTL) rose 32.6% to $7.37 in pre-market trading. Syncona said Blackstone Life Science will invest $250 million in Autolus. Mainz Biomed...
Via
Benzinga
Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting
November 04, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents Data on its NAM-Enabled NK Cell Therapies at Protein & Antibody Engineering Summit (PEGS) Europe
November 04, 2021
From
Gamida Cell Ltd.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.